Immune response to varicella vaccine in children with atopic dermatitis compared with nonatopic controls.
Schneider
Lynda
L
Weinberg
Adriana
A
Boguniewicz
Mark
M
Taylor
Patricia
P
Oettgen
Hans
H
Heughan
Lisa
L
Zaccaro
Daniel
D
Armstrong
Brian
B
Holliday
Aaron
A
Leung
Donald Y M
DY
D000956:Antigens, Viral / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism* / Q000473:pathology / Q000821:virology; D002478:Cells, Cultured; D019433:Chickenpox Vaccine / Q000008:administration & dosage* / Q000009:adverse effects; D002675:Child, Preschool; D003876:Dermatitis, Atopic / Q000097:blood / Q000150:complications / Q000276:immunology* / Q000503:physiopathology; D018450:Disease Progression; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006566:Herpesviridae Infections / Q000097:blood / Q000150:complications / Q000276:immunology* / Q000503:physiopathology; D014645:Herpesvirus 3, Human / Q000276:immunology* / Q000472:pathogenicity; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D007223:Infant; D007371:Interferon-gamma / Q000378:metabolism; D007617:Kaposi Varicelliform Eruption; D008213:Lymphocyte Activation; D008297:Male
D000956:Antigens, Viral; D019433:Chickenpox Vaccine; D007073:Immunoglobulin E; D007371:Interferon-gamma